MedTrace Logo

Pharmacokinetics With a New Oral Nicotine Replacement Product and Nicorette® Gum

NCT01152736 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2012-07-10

No results posted yet for this study

Summary

Single-dose pharmacokinetics with a new oral nicotine replacement product and Nicorette® gum.

Conditions

  • Tobacco Dependence

Interventions

DRUG

Nicotine

2 mg Single-dose

Sponsors & Collaborators

  • McNeil AB

    lead INDUSTRY

Principal Investigators

  • Elisabeth Kruse, PhD · McNeil AB

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2008-12-31
Completion
2009-01-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01152736 on ClinicalTrials.gov